Literature DB >> 32386602

Hyperinsulinemia Drives Epithelial Tumorigenesis by Abrogating Cell Competition.

Yuya Sanaki1, Rina Nagata1, Daisuke Kizawa1, Pierre Léopold2, Tatsushi Igaki3.   

Abstract

Metabolic diseases such as type 2 diabetes are associated with increased cancer incidence. Here, we show that hyperinsulinemia promotes epithelial tumorigenesis by abrogating cell competition. In Drosophila eye imaginal epithelium, oncogenic scribble (scrib) mutant cells are eliminated by cell competition when surrounded by wild-type cells. Through a genetic screen, we find that flies heterozygous for the insulin receptor substrate chico allow scrib cells to evade cell competition and develop into tumors. Intriguingly, chico is required in the brain's insulin-producing cells (IPCs) to execute cell competition remotely. Mechanistically, chico downregulation in IPCs causes hyperinsulinemia by upregulating a Drosophila insulin Dilp2, which activates insulin-mTOR signaling and thus boosts protein synthesis in scrib cells. A diet-induced increase in insulin levels also triggers scrib tumorigenesis, and pharmacological repression of protein synthesis prevents hyperinsulinemia-induced scrib overgrowth. Our findings provide an in vivo mechanistic link between metabolic disease and cancer risk via systemic regulation of cell competition.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drosophila; cancer; cell competition; hyperinsulinemia; insulin; tumor suppression

Mesh:

Substances:

Year:  2020        PMID: 32386602     DOI: 10.1016/j.devcel.2020.04.008

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  13 in total

1.  WASH activation controls endosomal recycling and EGFR and Hippo signaling during tumor-suppressive cell competition.

Authors:  Dan Liu; Vasilios Tsarouhas; Christos Samakovlis
Journal:  Nat Commun       Date:  2022-10-21       Impact factor: 17.694

Review 2.  Emerging mechanisms of cell competition.

Authors:  Nicholas E Baker
Journal:  Nat Rev Genet       Date:  2020-08-10       Impact factor: 53.242

Review 3.  Tumour-host interactions through the lens of Drosophila.

Authors:  David Bilder; Katy Ong; Tsai-Ching Hsi; Kavya Adiga; Jung Kim
Journal:  Nat Rev Cancer       Date:  2021-08-13       Impact factor: 60.716

Review 4.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

Review 5.  Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors.

Authors:  Mariusz Dąbrowski
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

6.  Genetic manipulation of insulin/insulin-like growth factor signaling pathway activity has sex-biased effects on Drosophila body size.

Authors:  Jason W Millington; George P Brownrigg; Paige J Basner-Collins; Ziwei Sun; Elizabeth J Rideout
Journal:  G3 (Bethesda)       Date:  2021-03-16       Impact factor: 3.154

7.  Prognostic significance of preoperative haemoglobin A1c level in patients with lung adenocarcinoma.

Authors:  Hiroyuki Ogawa; Yusuke Fujibayashi; Megumi Nishikubo; Yuki Nishioka; Shinya Tane; Yoshitaka Kitamura; Wataru Nishio
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-04

Review 8.  Mechanism of tumor-suppressive cell competition in flies.

Authors:  Hiroshi Kanda; Tatsushi Igaki
Journal:  Cancer Sci       Date:  2020-08-01       Impact factor: 6.716

Review 9.  Metabolic Hormones Modulate Macrophage Inflammatory Responses.

Authors:  Matthew J Batty; Gwladys Chabrier; Alanah Sheridan; Matthew C Gage
Journal:  Cancers (Basel)       Date:  2021-09-17       Impact factor: 6.639

Review 10.  Metabolic reprogramming in cancer: mechanistic insights from Drosophila.

Authors:  Kenneth Kin Lam Wong; Esther M Verheyen
Journal:  Dis Model Mech       Date:  2021-07-09       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.